Abstract
Toxicity from intermediate-dose methotrexate (MTX) is unusual. A severely obese adolescent with acute lymphoblastic leukemia experienced significant, delayed nephrotoxicity from intermediate-dose MTX. Altered MTX disposition may occur as a consequence of other ingestions or conditions such as obesity. The use of radioisotope renography established the diagnosis and followed the resolution of the patient's MTX-induced nephrotoxicity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 135-140 |
| Number of pages | 6 |
| Journal | Pediatric hematology and oncology |
| Volume | 19 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2002 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute lymphoblastic leukemia
- Methotrexate
- Nephrotoxicity
- Obesity
- Renogram
Fingerprint
Dive into the research topics of 'Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS